Cargando…
Simultaneous spectrophotometric determination of finasteride and tadalafil in recently FDA approved Entadfi™ capsules
Entadfi™ is a recently FDA approved pharmaceutical combination capsule of finasteride and tadalafil. It was prescribed for the treatment of urinary tract disorders caused by benign prostatic hyperplasia in men. This paper introduced the first spectrophotometric methods for simultaneous determination...
Autores principales: | Abdelazim, Ahmed H., Ramzy, Sherif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335989/ https://www.ncbi.nlm.nih.gov/pubmed/35906639 http://dx.doi.org/10.1186/s13065-022-00850-w |
Ejemplares similares
-
Green adherent spectrophotometric determination of molnupiravir based on computational calculations; application to a recently FDA-approved pharmaceutical dosage form
por: Abdelazim, Ahmed H., et al.
Publicado: (2023) -
Development of validated methods for the simultaneous quantification of Finasteride and Tadalafil in newly launched FDA-approved therapeutic combination: greenness assessment using AGP, analytical eco-scale, and GAPI tools
por: Kammoun, Ahmed K., et al.
Publicado: (2023) -
Adjusted green HPLC determination of nirmatrelvir and ritonavir in the new FDA approved co-packaged pharmaceutical dosage using supported computational calculations
por: Imam, Mohamed S., et al.
Publicado: (2023) -
Spectrophotometric quantitative analysis of remdesivir using acid dye reagent selected by computational calculations
por: Abdelazim, Ahmed H., et al.
Publicado: (2022) -
Application of different spectrophotometric methods for quantitative analysis of direct acting antiviral drugs simeprevir and sofosbuvir
por: Ramzy, Sherif, et al.
Publicado: (2022)